Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2024
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registryMar Riveiro-Barciela, Ana Barreira-Díaz, Paula Esteban, et al.
Hepatology Communications|January 6, 2022
Noninvasive Prediction of Outcomes in Autoimmune Hepatitis-Related CirrhosisLaura-Patricia Llovet, Jordi Gratacós-Ginès, Luis Téllez, et al.
Gastroenterologia Y Hepatologia|August 26, 2023
Spontaneously ruptured hepatocellular carcinoma on non-cirrhotic liver: A prospective case seriesMarta Romero-Gutiérrez, Sonia Pascual, Laura Márquez, et al.
Revista Espanola De Enfermedades Digestivas|December 18, 2025
Hepatocellular carcinoma in non-cirrhotic liver: a prospective Spanish multicenter studyMarta Romero Gutiérrez, Sonia Pascual, Mariano Gómez-Rubio, et al.
Alimentary Pharmacology & Therapeutics|August 26, 2025
Unveiling Drug-Induced Autoimmune-Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective StudyPinelopi Arvaniti, Ignasi Olivas, Ana Pascual-Dapena, et al.
Hepatology (Baltimore, Md.)|January 10, 2023
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administrationÁlvaro Díaz-González, Manuel Hernández-Guerra, Indhira Pérez-Medrano, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2025
Occurrence and Management of Opportunistic Infections in Patients With Autoimmune Hepatitis: A Spanish Multicentre StudyMaría Del Barrio, Elena Ferreiro, Elena Gómez, et al.
JHEP Reports : Innovation in Hepatology|October 16, 2025
Isolated IgG elevation in patients with persistently normal transaminases does not affect the outcome of autoimmune hepatitisÁlvaro Díaz-González, Ida Schregel, Lorena Carballo, et al.
Pageof 3